ALR Technologies Inc.
ALRTF
Other OTC0.02
USD
- -
- -
CIK
0001930419
ISIN
SGXZ33978792
Return %
Stock
S&P500
1Y
50.00
17.85
3Y
-58.49
64.56
5Y
-72.22
69.89
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Sidney S. Chan
- Full Time Employees
- 7
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 7400 Beaufont Springs Drive Singapore VA Singapore 23225
- IPO Date
- Dec 23, 1998
- CIK
- 0001930419
- Website
- alrt.com
- Similar Companies
- Business
- ALR Technologies Inc. is a medical device and data management company specializing in diabetes care management solutions for both human and animal health. The company offers the ALRT Diabetes Solution, a comprehensive diabetes management system that collects data directly from blood glucose meters and continuous glucose monitoring (CGM) devices. It also provides a Predictive A1C algorithm for tracking treatment success between lab reports and an FDA-cleared Insulin Dosing Adjustment program. For animal health, ALR Technologies markets the GluCurve Pet CGM, a continuous glucose monitoring system designed for diabetic cats and dogs. ALR Technologies operates primarily in North America and Asia, with corporate headquarters originally in the United States and a jurisdiction reincorporation in Singapore to support its global business strategy. It serves healthcare providers, clinics, and veterinarians offering remote monitoring and care facilitation technologies to improve patient and pet health outcomes by connecting clinicians with patients and testing supplies through digital platforms. Recent major developments include a definitive manufacturing agreement with CGM Medical Technology Shen Zhen Ltd. in China for the GluCurve Pet CGM hardware and a co-branded distribution partnership with Covetrus, a global leader in animal-health technology, to expand the GluCurve Pet CGM's market reach. The company also completed a pivotal non-inferiority clinical study for the GluCurve Pet CGM and launched its integrated ALRT Diabetes Solution to healthcare providers, facilitating enterprise-scale diabetes care management. In addition, ALR Technologies has undergone a strategic reorganization including a redomicile merger to Singapore and continues to expand its product portfolio and market presence through new partnerships and manufacturing agreements within the last two years. Founded in 1997 and headquartered in Massachusetts, ALR Technologies positions itself as a leader in advancing diabetes care through innovative monitoring technologies and data-driven health management systems for both human and animal markets.
ALR Technologies Announces Strategic Acquisition of CGM Medical Technology for US$45 Million & 200M Shares
ALR Technologies Announces Strategic Acquisition of CGM Medical Technology for US$45 Million & 200M Shares
ALR TECHNOLOGIES HAS LAUNCHED THE GLUCURVE PET CGM IN CANADA
ALR TECHNOLOGIES TO RELAUNCH THE GLUCURVE PET CGM IN JANUARY 2026
ALR Technologies Completes Definitive Manufacturing Agreement for GluCurve Pet CGM
ALR Technologies Announces Patent Grant for Predictive A1C and Successful Results from Singapore General Hospital-led Study
ALR Technologies Announces Canadian Launch Plans for the GluCurve Pet CGM